Arcoma AB

As of June 30, 2026, Arcoma AB carries a market capitalization of 127.63M, placing it among publicly traded companies globally. Its enterprise value stands at 96.73M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Arcoma AB's next confirmed earnings release is scheduled for October 22, 2026.

As of June 30, 2026, Arcoma AB has 14.31M shares outstanding.

As of June 30, 2026, Arcoma AB trades at a trailing price-to-earnings ratio of 49.54. The price-to-sales ratio is 0.97, and the price-to-book ratio stands at 1.68.

As of June 30, 2026, Arcoma AB trades at an EV/EBITDA multiple of 10.75 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.75 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 33.01 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Arcoma AB trades at an EV/FCF ratio of 6.94, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 96.73M versus a market cap of 127.63M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Arcoma AB maintains a current ratio of 3.37, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Arcoma AB posted a return on equity (ROE) of 3.68, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 3.42 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 2.63, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 3.81, useful for judging operating efficiency across full business cycles. The company generates approximately 4.19M in revenue per employee across its workforce of 30.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.83 indicates how many times Arcoma AB sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Arcoma AB recorded 624,000.00 in income tax expense. That works out to an effective tax rate of 19.81, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 3.15M, leaving 2.53M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Arcoma AB's stock has declined approximately 13.98% over the past 52 weeks. The 50-day moving average sits at 7.85, while the 200-day moving average is 8.05.

Over the twelve months ended June 30, 2026, Arcoma AB generated 128.77M in revenue and converted that into 2.53M in net income, yielding earnings per share of 0.18. EBITDA reached 9.00M, while operating income came in at 2.93M.

These figures are as of June 30, 2026. Total book value stands at 75.85M, with working capital of 56.09M providing operational flexibility.

Arcoma AB produced 18.71M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -4.87M in capital expenditures, free cash flow totaled 13.84M - equivalent to 0.99 per share.

Over the twelve months ended June 30, 2026, Arcoma AB posted a gross margin of 39.16, reflecting its pricing power and cost economics. The operating margin of 2.28 and net profit margin of 1.96 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 11.06, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches - -, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Arcoma AB shareholders.

Arcoma AB's most recent stock split took place on September 21, 2015 with a 17:18 split ratio.